Sichuan Kelun Pharmaceutical Co Ltd is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of a wide range ...Read more
10,000+
N/A
kelun.com
Public
Find prospects by the technologies they use. Use this section to learn more about key technologies and tools, tracked by 6sense, used by Sichuan Kelun Pharmaceutical Co Ltd
Are you looking for the decision-makers at Sichuan Kelun Pharmaceutical Co Ltd? Get their email address, phone numbers, and other details from Linkedin or any website. Install and uncover Sichuan Kelun Pharmaceutical Co Ltd’s employee details in less than 30 secs.
Sign-up for 6sense Revenue AI™ for Sales
To find emails, direct dials, and more for prospects across the web.
Sign Up TodayDiscover Sichuan Kelun Pharmaceutical Co Ltd alternatives or similar companies to benchmark and competitors market analysis. Build a competitive intelligence sales and marketing strategy based on the data and stand out in the market.
Wabtec Corporation (Westinghouse Air Brake Technologies)
10,000+
Wilmerding
wabtec.com
Public
N/A
Chengdu Chuanghong Machinery Equipment Leasing Co. Ltd.
0 - 9
Chengdu
N/A
N/A
N/A
N/A
Chengdu Mika Ruiwan Commerce & Trade Co. Ltd.
0 - 9
Chengdu
N/A
N/A
N/A
N/A
Jilin Dasai Sien New Type Construction Material Co. Ltd.
0 - 9
Changchun
N/A
N/A
N/A
N/A
Riyad Bank
5,000 - 9,999
Riyadh
riyadbank.com
Public
N/A
Sales prospecting needs to be timely and appropriate for the person and organization you are contacting. Following the most recent company news, alerts, and updates about the leads you are currently working on is the simplest and most convenient way to stay on top of them. Here are Sichuan Kelun Pharmaceutical Co Ltd latest news, alerts and updates.
Kelun-Biotech raises $174M in Hong Kong IPO to race in ADC market
Kelun-Biotech Biopharmaceutical Co. Ltd. raised HK$1.36 billion (US$174 million) in an IPO in Hong Kong to support its push into the increasingly competitive antibody-drug conjugate (ADC) market in China.
11 Jul 2023
China's Sichuan Kelun-Biotech opens books for $208 million Hong Kong IPO - term sheet
China's Sichuan Kelun-Biotech Pharmaceutical is looking to raise $208.6 million in a Hong Kong initial public offering, according to a term sheet seen by Reuters. The company is selling 22.44 million shares in a price range of HK$60.
28 Jun 2023
Explore frequently asked questions about Sichuan Kelun Pharmaceutical Co Ltd’s business, including founding details, header quarters, information on technology stack, industry listing, and other details.
How many employees are working at Sichuan Kelun Pharmaceutical Co Ltd?
What industry is Sichuan Kelun Pharmaceutical Co Ltd in?
What is Sichuan Kelun Pharmaceutical Co Ltd's tech stack?
Where are Sichuan Kelun Pharmaceutical Co Ltd's headquarters?